Viatris

Viatris is a global pharmaceutical and healthcare leader committed to delivering high-quality, clinically reliable and affordable medicines across a broad range of therapeutic areas. Formed through the integration of scientific expertise, regulated manufacturing and industry innovation, Viatris provides accessible treatment options designed to strengthen healthcare systems worldwide. Patients and healthcare providers trust Viatris for chronic condition management, preventive care and acute medical needs—each product guided by strict global regulatory standards.

Extensive Portfolio of Clinically Validated Healthcare Solutions

Viatris offers a comprehensive selection of prescription medicines, generics, complex therapies, biologics, biosimilars, vaccines and consumer health products. Its wide therapeutic coverage supports essential areas of modern medicine, including:

• Cardiology
• Oncology support
• Endocrinology
• Neurology
• Allergy and immune treatments
• Women’s health
• Infectious diseases
• Respiratory disorders
• Dermatology
• Gastrointestinal care

This diverse portfolio ensures patients and clinicians have dependable access to regulated therapeutic solutions designed for both acute and long-term care.

Uncompromising Focus on Quality, Safety and Standards

Reliable treatment depends on medicines that deliver consistent quality, accurate dosing and proven therapeutic performance. Viatris maintains these standards through:

• Advanced laboratory analysis and quality testing
• Stability and bioequivalence studies
• Ingredient verification and authentication
• Precision-driven manufacturing processes

All Viatris facilities operate under Good Manufacturing Practices (GMP) and internationally recognised regulatory requirements, protecting patients from unsafe, ineffective or unregulated pharmaceutical products.

Improving Access with Affordable Medicines

Affordability is a core component of the Viatris mission. The company supports long-term disease management by offering cost-effective medicines essential for conditions such as:

• Hypertension
• Diabetes
• Asthma
• Cardiovascular disease
• Autoimmune disorders

These accessible, clinically validated therapies help reduce financial barriers and improve treatment adherence for patients worldwide.

Advancing Global Healthcare Through Biosimilars

Viatris is internationally recognised for its leadership in biosimilars, offering high-quality, clinically equivalent alternatives to expensive biologic medicines. These treatments support access in critical therapeutic categories such as:

• Oncology
• Inflammatory diseases
• Autoimmune conditions

By expanding access to advanced therapies, Viatris plays a vital role in promoting healthcare equity across both developed and emerging markets.

Clear, Responsible Pharmaceutical Communication

Every Viatris product includes detailed, transparent labelling to support safe and effective use. Clinical documentation features:

• Accurate dosing information
• Indications and contraindications
• Storage and handling requirements
• Warnings, precautions and guidance for safe use

These clear standards help patients and healthcare professionals make informed care decisions and manage treatment responsibly.

Ethical, Secure and Regulated Distribution

To protect patients from counterfeit or unsafe medicines, Viatris maintains strong, highly regulated global supply chains. Products are distributed exclusively through:

• Licensed pharmacies
• Hospitals
• Approved healthcare providers

This ensures every patient receives only authentic, properly manufactured and fully compliant medication.

Global Commitment to Stronger Healthcare Systems

With its global infrastructure, scientific innovation and dedication to affordability, Viatris continues to advance safe, accessible and high-quality treatment options worldwide. Its mission supports a healthier future built on reliability, patient trust and regulated pharmaceutical excellence.

Frequently Asked Questions

What types of medicines does Viatris provide?
Viatris offers prescription medicines, generics, biologics, biosimilars, vaccines and consumer healthcare products across numerous therapeutic categories.

Are Viatris medicines safe and regulated?
Yes. All Viatris products follow GMP standards, international regulations and rigorous quality testing.

Why are Viatris biosimilars important?
They provide clinically equivalent alternatives to expensive biologic treatments, improving global access and affordability.

Where can Viatris medicines be obtained?
They are available exclusively through licensed pharmacies, hospitals and authorised healthcare providers.

Does Viatris support affordable long-term treatment?
Yes. Affordability and continuity of care are central to the company’s commitment to better health outcomes.